Risk score for pediatric intensive care unit admission in children undergoing hematopoietic stem cell transplantation and analysis of predictive factors for survival

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 10, 2005, Pages 526-531

  González Vicent, Marta ^a   Marín, Catalina ^a   Madero, Luis ^a   Sevilla, Julián ^a   Díaz, Miguel Angel ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Children; Hematopoietic transplantation; PICU

Indexed keywords

AMPHOTERICIN B; BUSULFAN; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; FEBRILE NEUTROPENIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL MORTALITY; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; NEOPLASMS; PATIENT ADMISSION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 27544439059     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000184637.94923.11     Document Type: Article

References (43)

1. Roberts I. Bone marrow transplantation in children: current results and controversies. Bone Marrow Transplant. 1994;14:197-199.
2. Rossi R, Shemie S, Calderwood S. Prognosis of pediatric bone marrow transplant recipients requiring mechanical ventilation. Crit Care Med. 1999;27:1181-1186.
3. Díaz MA. G. Vicent M and Madero L. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors. Bone Marrow Transplant. 1999;24:1157-1159.
4. Díaz MA, Villa M, Alegre A, et al. Collection and transplantation of peripheral blood progenitor cells mobilized by G-CSF alone in children with malignancies. Br J Haematol. 1996;94:148-154.
5. Diaz MA, Alegre A, Villa M, et al. Allogeneic peripheral blood progenitor cells (PBPC) transplantation in children with haematologial malignancies. Br J Haematol. 1997;96:161-164.
6. De la Rubia J, Diaz MA, Verdeguer A, et al. Donor age-related differences in PBPC mobilization with rHud-CSF. Transfusion. 2001;41:201-205.
7. Diaz MA, Sevilla J, de la Rubia J, et al. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica. 2003;88:919-922.
8. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825.
9. Shullman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
10. Farmer ER. The histopathology of graft-versus-host disease. Adv Dermatol. 1986;1:173-188.
11. Haire WD, Ruby El, Stephens LC, et al. A prospective, randomized, double-blind trial of antithrombin III concentrate in the treatment of multiple organ dysfunction syndrome during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 1998;4:142-150.
12. Wilkinson JD, Pollack MM, Glass NL. Mortality associated with multiple organ system failure and sepsis in paediatric ICU. J Pediatr. 1987;111:324-328.
13. Lee CK, Gingrich RD, Hohl RJ, et al. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant. 1996;16:175-182.
14. Schneider DT, Lemburg P, Sprock I, et al. Introduction of the Oncological Pediatric Risk of Mortality score (O-PRISM) for ICU support following stem cell transplantation in children. Bone Marrow Transplant. 2000;25:1079-1086.
15. Cox DR. Regression models and life tables. J Roy Stat Soc. 1972;34:187-220.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Slat Assoc. 1958;53:457-481.
17. Diaz MA, Gonzalez-Vicent M, Prudencio M, et al. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica. 2002;87:292-298.
18. Crawford S, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant. 1993;12:225-231.
19. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St. Jude Children's Research Hospital. Leukemia. 2000;94:2286-2294.
20. Afessa B, Litzow MR, Tefferi A, et al. Bronchiolitis obliterans and other late non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:425-434.
21. Capizzi SA, Kumar S, Huneke NE, et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:1299-1303.
22. Gonzalez-Vicent M, Ramirez M, Sevilla J, et al. Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome. Bone Marrow Transplant. 2004;34:1051-1055.
23. Warwick AB, Mertens AC, Ou Shou X, et al. Outcomes following mechanical ventilation in children undergoing bone marrow transplantation. Bone Marrow Transplant. 1998;22:787-794.
24. Diaz de Heredia C, Moreno A, Olive T, et al. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications. Bone Marrow Transplant. 1999;24:163-168.
25. Todd K, Wiley F, Landaw E, et al. Survival outcome among 54 intubated pediatric bone marrow transplant patients. Crit Care Med. 1994;22:171-176.
26. Hayes C, Lush RJ, Cornish J, et al. The outcome of children requiring admission to an intensive care unit following bone marrow transplantation. Br J Haematol. 1998;102:666-670.
27. Lamas A, Otheo E, Ros P, et al. Prognosis of child recipients of hematopoietic stem cell transplantation requiring intensive care. Intensive Care Med. 2003;29:91-96.
28. Tomaske M, Bosk A, Eyrich M, et al. Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation. Br J Haematol. 2003;121:886-891.
29. Jacobe SJ, Hassan A, Veys P, et al. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Crit Care Med. 2003;31:1299-1305.
30. Weiner RS, Mortimer MB, Gale RP, et al. Interstitial pneumonitis after bone marrow transplantation. Ann Intern Med. 1986;104:168-175.
31. Clark J, Hansen J, Hertz M, et al. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Resp Dis. 1993;147:1601-1606.
32. Kantrow SP, Hackman RC, Boeckh M, et al. Idiopathic pneumonia syndrome changing spectrum of lung injury after marrow transplantation. Transplantation. 1997;63:1079-1086.
33. Bach PB, Schrag D, Nierman DM, et al. Identification of poor prognotic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood. 2001;98:3234-3240.
34. Fukuda T, Hackman RC, Guthrie KA, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood. 2003;102:2777-2785.
35. Cooke KR, Yanik G. Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant. 2004;34:753-765.
36. Schneider DT, Cho J, Laws HJ, et al. Serial evaluation of the Oncological Pediatric Risk of Mortality (O-PRISM) score following allogeneic bone marrow transplantation in children. Bone Marrow Transplant. 2002;29:383-389.
37. Price KJ, Thall PF, Kish SK, et al. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med. 1998;158:876-884.
38. Keenan HT, Bratton SL, Martin LD, et al. Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit Care Med. 2000;28:830-835.
39. DiCarlo JV, Alexander SR, Agarwal R, et al. Continous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol. 2003;25:801-805.
40. Sen S, Jalan R, Morris EC, et al. Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support device. Transplantation. 2003;75:1766-1767.
41. Yanik G, Hellerstedt B, Custer J, et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2002;8:395-400.
42. Gonzalez-Vicent M, Diaz MA, Sevilla J, et al. Cerebral toxoplasmosis following etanercept therapy for idiopathic pneumonia syndrome after autologous peripheral progenitor cell transplantation (PBPCT). Ann Hematol. 2003;82:649-653.
43. Krijanovski OI, Hill GR, Cooke KR, et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood. 1999;94:825-831.